Literature DB >> 21607131

Immune regulatory properties of multipotent mesenchymal stromal cells: Where do we stand?

Enio José Bassi1, Carlos Alberto Mayora Aita, Niels Olsen Saraiva Câmara.   

Abstract

Multipotent mesenchymal stromal cells (MSC) can be isolated and efficiently expanded from almost every single body tissue and have the ability of self-renewal and differentiation into various mesodermal cell lineages. Moreover, these cells are considered immunologically privileged, related to a lack of surface expression of costimulatory molecules required for complete T cell activation. Recently, it has been observed that MSC are capable of suppressing the immune response by inhibiting the maturation of dendritic cells and suppressing the function of T lymphocytes, B lymphocytes and natural killer cells in autoimmune and inflammatory diseases as a new strategy for immunosuppression. The understanding of immune regulation mechanisms by MSC is necessary for their use as immunotherapy in clinical applications for several diseases.

Keywords:  Autoimmune disease; Immune system; Immunosuppression; Inflammation; Mesenchymal stem cell

Year:  2011        PMID: 21607131      PMCID: PMC3097934          DOI: 10.4252/wjsc.v3.i1.1

Source DB:  PubMed          Journal:  World J Stem Cells        ISSN: 1948-0210            Impact factor:   5.326


  64 in total

Review 1.  Mesenchymal stem cells: the fibroblasts' new clothes?

Authors:  Muzlifah A Haniffa; Matthew P Collin; Christopher D Buckley; Francesco Dazzi
Journal:  Haematologica       Date:  2008-12-23       Impact factor: 9.941

2.  Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner.

Authors:  Moutih Rafei; Philippe M Campeau; Adriana Aguilar-Mahecha; Marguerite Buchanan; Patrick Williams; Elena Birman; Shala Yuan; Yoon Kow Young; Marie-Noëlle Boivin; Kathy Forner; Mark Basik; Jacques Galipeau
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

3.  Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes.

Authors:  Paolo Fiorina; Mollie Jurewicz; Andrea Augello; Andrea Vergani; Shirine Dada; Stefano La Rosa; Martin Selig; Jonathan Godwin; Kenneth Law; Claudia Placidi; R Neal Smith; Carlo Capella; Scott Rodig; Chaker N Adra; Mark Atkinson; Mohamed H Sayegh; Reza Abdi
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

4.  Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis.

Authors:  Moutih Rafei; Elena Birman; Kathy Forner; Jacques Galipeau
Journal:  Mol Ther       Date:  2009-07-14       Impact factor: 11.454

5.  Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6.

Authors:  Ryang Hwa Lee; Andrey A Pulin; Min Jeong Seo; Daniel J Kota; Joni Ylostalo; Benjamin L Larson; Laura Semprun-Prieto; Patrice Delafontaine; Darwin J Prockop
Journal:  Cell Stem Cell       Date:  2009-07-02       Impact factor: 24.633

6.  MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

Authors:  Grazia Maria Spaggiari; Heba Abdelrazik; Flavio Becchetti; Lorenzo Moretta
Journal:  Blood       Date:  2009-04-27       Impact factor: 22.113

7.  Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells.

Authors:  A M Madec; R Mallone; G Afonso; E Abou Mrad; A Mesnier; A Eljaafari; C Thivolet
Journal:  Diabetologia       Date:  2009-05-07       Impact factor: 10.122

8.  Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia.

Authors:  Imene Boumaza; Suganya Srinivasan; William T Witt; Carol Feghali-Bostwick; Yifan Dai; Adolfo Garcia-Ocana; Maryam Feili-Hariri
Journal:  J Autoimmun       Date:  2008-12-04       Impact factor: 7.094

9.  Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression.

Authors:  Guangwen Ren; Juanjuan Su; Liying Zhang; Xin Zhao; Weifang Ling; Andrew L'huillie; Jimin Zhang; Yongqing Lu; Arthur I Roberts; Weizhi Ji; Huatang Zhang; Arnold B Rabson; Yufang Shi
Journal:  Stem Cells       Date:  2009-08       Impact factor: 6.277

10.  Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.

Authors:  Manuel A González; Elena Gonzalez-Rey; Laura Rico; Dirk Büscher; Mario Delgado
Journal:  Arthritis Rheum       Date:  2009-04
View more
  38 in total

1.  Human endometrial-derived mesenchymal stem cells suppress inflammation in the central nervous system of EAE mice.

Authors:  J P S Peron; T Jazedje; W N Brandão; P M Perin; M Maluf; L P Evangelista; S Halpern; M G Nisenbaum; C E Czeresnia; M Zatz; N O S Câmara; L V Rizzo
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

2.  Induction of ALP and MMP9 activity facilitates invasive behavior in heterogeneous human BMSC and HNSCC 3D spheroids.

Authors:  Anja Wessely; Anna Waltera; Torsten E Reichert; Sabine Stöckl; Susanne Grässel; Richard J Bauer
Journal:  FASEB J       Date:  2019-07-31       Impact factor: 5.191

Review 3.  Vibration stimuli and the differentiation of musculoskeletal progenitor cells: Review of results in vitro and in vivo.

Authors:  Jennifer Helen Edwards; Gwendolen Clair Reilly
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

Review 4.  Secretion of immunoregulatory cytokines by mesenchymal stem cells.

Authors:  Dobroslav Kyurkchiev; Ivan Bochev; Ekaterina Ivanova-Todorova; Milena Mourdjeva; Tsvetelina Oreshkova; Kalina Belemezova; Stanimir Kyurkchiev
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

5.  Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.

Authors:  Qiushi Wang; Qiaoni Yang; Zhe Wang; Haixia Tong; Liangyan Ma; Yi Zhang; Fengping Shan; Yiming Meng; Zhengwei Yuan
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

6.  Mesenchymal stromal cells treatment attenuates dry eye in patients with chronic graft-versus-host disease.

Authors:  Jianyu Weng; Chang He; Peilong Lai; Chenwei Luo; Rong Guo; Suijing Wu; Suxia Geng; Andy Xiangpeng; Xialin Liu; Xin Du
Journal:  Mol Ther       Date:  2012-10-16       Impact factor: 11.454

Review 7.  Concise review: the periosteum: tapping into a reservoir of clinically useful progenitor cells.

Authors:  Hana Chang; Melissa L Knothe Tate
Journal:  Stem Cells Transl Med       Date:  2012-05-30       Impact factor: 6.940

8.  Systemic Neutrophil Depletion Modulates the Migration and Fate of Transplanted Human Neural Stem Cells to Rescue Functional Repair.

Authors:  Hal X Nguyen; Mitra J Hooshmand; Hirokazu Saiwai; Jake Maddox; Arjang Salehi; Anita Lakatos; Rebecca A Nishi; Desiree Salazar; Nobuko Uchida; Aileen J Anderson
Journal:  J Neurosci       Date:  2017-08-28       Impact factor: 6.167

9.  MALP-2, an agonist of TLR6, promotes the immune status without affecting the differentiation capacity of umbilical cord mesenchymal stem cells.

Authors:  Xiuli Wu; Lian Xu; Yangmei Shen; Na Yu; Yan Zhang; Tao Guo
Journal:  Exp Ther Med       Date:  2017-10-03       Impact factor: 2.447

10.  CD39-mediated effect of human bone marrow-derived mesenchymal stem cells on the human Th17 cell function.

Authors:  Jong Joo Lee; Hyun Jeong Jeong; Mee Kum Kim; Won Ryang Wee; Won Woo Lee; Seung U Kim; Changmin Sung; Yung Hun Yang
Journal:  Purinergic Signal       Date:  2013-09-17       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.